Iceland· IS-EU/1/16/1135/001-002
Sialanar
A glycopyrronium bromid product containing glycopyrronii bromidum inn, registered in Iceland by Proveca Pharma Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Glycopyrronium bromid is registered in 12 of 19 countries.
Countries holding a registration under ATC A03AB02 (glycopyrronium bromid), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Glycopyrronium bromid · ATC A03AB02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Glycopyrronii bromidum INN
- Manufacturer
- Proveca Pharma Limited
- Country
- Iceland (IS)
- ATC code
- A03AB02
- ATC class
- Glycopyrronium bromid
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean976459250 ml x1 flISK 95340
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycopyrronium bromid in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAxhidrox 8 mg/g, crèmeEuro Registratie Collectief B.V.
- PolandAMIDIL AmiHalerZakłady Farmaceutyczne POLPHARMA S.A.
- ItalyGLICOPIRRONIO DOCDOC GENERICI S.R.L.
- SpainAXHIDROX 2,2 MG/PULSACION CREMAIndustrial Farmaceutica Cantabria S.A.
- SwitzerlandAxhidrox 2,2 mg/Hub, CremeGebro Pharma AG
- United StatesQbrexzaJourney Medical Corporation
- GermanyRybrilaColonis Pharma B.V.
- DenmarkEnurev BreezhalerNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Rybrila
- Germany · Rybrila
- Spain · Axhidrox
- Sweden · Glycopyrronium Cantabria
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55b37991-d08b-4842-bdc6-24eeb164f8a1 GET /v1/drugs/55b37991-d08b-4842-bdc6-24eeb164f8a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Mixtúra, lausn",
"source": "lyfjastofnun",
"atc_raw": "A03AB02",
"marketed": false,
"strength": "320 míkróg/ml",
"ma_number": "EU/1/16/1135/001-002",
"substance": "Glycopyrronii bromidum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í taugalækningum og barnalækningum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "42628"
}See everything about glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.